<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">33669273</PMID><DateCompleted><Year>2021</Year><Month>08</Month><Day>09</Day></DateCompleted><DateRevised><Year>2024</Year><Month>03</Month><Day>31</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1999-4915</ISSN><JournalIssue CitedMedium="Internet"><Volume>13</Volume><Issue>2</Issue><PubDate><Year>2021</Year><Month>Feb</Month><Day>16</Day></PubDate></JournalIssue><Title>Viruses</Title><ISOAbbreviation>Viruses</ISOAbbreviation></Journal><ArticleTitle>Polyamine Analog Diethylnorspermidine Restricts Coxsackievirus B3 and Is Overcome by 2A Protease Mutation In Vitro.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">310</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/v13020310</ELocationID><Abstract><AbstractText>Enteroviruses, including Coxsackievirus B3 (CVB3), are pervasive pathogens that cause significant disease, including cardiomyopathies. Unfortunately, no treatments or vaccines are available for infected individuals. We identified the host polyamine pathway as a potential drug target, as inhibiting polyamine biosynthesis significantly reduces enterovirus replication in vitro and in vivo. Here, we show that CVB3 is sensitive to polyamine depletion through the polyamine analog diethylnorspermidine (DENSpm), which enhances polyamine catabolism through induction of polyamine acetylation. We demonstrate that CVB3 acquires resistance to DENSpm via mutation of the 2A protease, which enhances proteolytic activity in the presence of DENSpm. Resistance to DENSpm occurred via mutation of a non-catalytic site mutation and results in decreased fitness. These data demonstrate that potential for targeting polyamine catabolism as an antiviral target as well as highlight a potential mechanism of resistance.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Hulsebosch</LastName><ForeName>Bridget M</ForeName><Initials>BM</Initials><Identifier Source="ORCID">0000-0001-7846-2801</Identifier><AffiliationInfo><Affiliation>Department of Microbiology and Immunology, Stritch School of Medicine, Loyola University Chicago, Maywood, IL 60153, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Infectious Disease and Immunology Research Institute, Stritch School of Medicine, Loyola University Chicago, Maywood, IL 60153, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mounce</LastName><ForeName>Bryan C</ForeName><Initials>BC</Initials><Identifier Source="ORCID">0000-0003-1710-5362</Identifier><AffiliationInfo><Affiliation>Department of Microbiology and Immunology, Stritch School of Medicine, Loyola University Chicago, Maywood, IL 60153, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Infectious Disease and Immunology Research Institute, Stritch School of Medicine, Loyola University Chicago, Maywood, IL 60153, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>R35 GM138199</GrantID><Acronym>GM</Acronym><Agency>NIGMS NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>02</Month><Day>16</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Viruses</MedlineTA><NlmUniqueID>101509722</NlmUniqueID><ISSNLinking>1999-4915</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000998">Antiviral Agents</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D011073">Polyamines</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D014764">Viral Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.4.22.-</RegistryNumber><NameOfSubstance UI="D003546">Cysteine Endopeptidases</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.4.22.29</RegistryNumber><NameOfSubstance UI="C057400">picornain 2A, Picornavirus</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000998" MajorTopicYN="N">Antiviral Agents</DescriptorName><QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName><QualifierName UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003546" MajorTopicYN="N">Cysteine Endopeptidases</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D024882" MajorTopicYN="N">Drug Resistance, Viral</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D029822" MajorTopicYN="N">Enterovirus B, Human</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="Y">drug effects</QualifierName><QualifierName UI="Q000201" MajorTopicYN="N">enzymology</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004769" MajorTopicYN="N">Enterovirus Infections</DescriptorName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009154" MajorTopicYN="N">Mutation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011073" MajorTopicYN="N">Polyamines</DescriptorName><QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014764" MajorTopicYN="N">Viral Proteins</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014779" MajorTopicYN="N">Virus Replication</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Coxsackievirus</Keyword><Keyword MajorTopicYN="N">enterovirus</Keyword><Keyword MajorTopicYN="N">polyamines</Keyword><Keyword MajorTopicYN="N">protease</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>1</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2021</Year><Month>2</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>2</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>3</Month><Day>6</Day><Hour>1</Hour><Minute>4</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>3</Month><Day>7</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>8</Month><Day>10</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2021</Year><Month>2</Month><Day>16</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">33669273</ArticleId><ArticleId IdType="pmc">PMC7920041</ArticleId><ArticleId IdType="doi">10.3390/v13020310</ArticleId><ArticleId IdType="pii">v13020310</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Strikas R.A., Anderson L.J., Parker R.A. Temporal and Geographic Patterns of Isolates of Nonpolio Enterovirus in the United States, 1970&#x2013;1983. J. Infect. Dis. 1986;153:346&#x2013;351. doi: 10.1093/infdis/153.2.346.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/infdis/153.2.346</ArticleId><ArticleId IdType="pubmed">3003207</ArticleId></ArticleIdList></Reference><Reference><Citation>Jubelt B., Lipton H.L. Chapter 18&#x2014;Enterovirus/Picornavirus infections. In: Tselis A.C., Booss J., editors. Handbook of Clinical Neurology. Volume 123. Elsevier; Amsterdam, The Netherlands: 2014. pp. 379&#x2013;416. Neurovirology.</Citation><ArticleIdList><ArticleId IdType="pubmed">25015496</ArticleId></ArticleIdList></Reference><Reference><Citation>Pons-Salort M., Parker E.P.K., Grassly N.C. The Epidemiology of Non-Polio Enteroviruses: Recent Advances and Outstanding Questions. Curr. Opin. Infect. Dis. 2015;28:479&#x2013;487. doi: 10.1097/QCO.0000000000000187.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/QCO.0000000000000187</ArticleId><ArticleId IdType="pmc">PMC6624138</ArticleId><ArticleId IdType="pubmed">26203854</ArticleId></ArticleIdList></Reference><Reference><Citation>Chapman N. Persistent Coxsackievirus Infection: Enterovirus Persistence in Chronic Myocarditis and Dilated Cardiomyopathy. Curr. Top. Microbiol. Immunol. 2008;323:275&#x2013;292.</Citation><ArticleIdList><ArticleId IdType="pubmed">18357775</ArticleId></ArticleIdList></Reference><Reference><Citation>Chuang Y.-Y., Huang Y.-C. Enteroviral Infection in Neonates. J. Microbiol. Immunol. Infect. 2019;52:851&#x2013;857. doi: 10.1016/j.jmii.2019.08.018.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jmii.2019.08.018</ArticleId><ArticleId IdType="pubmed">31607572</ArticleId></ArticleIdList></Reference><Reference><Citation>Garmaroudi F.S., Marchant D., Hendry R., Luo H., Yang D., Ye X., Shi J., McManus B.M. Coxsackievirus B3 Replication and Pathogenesis. Future Microbiol. 2015;10:629&#x2013;653. doi: 10.2217/fmb.15.5.</Citation><ArticleIdList><ArticleId IdType="doi">10.2217/fmb.15.5</ArticleId><ArticleId IdType="pubmed">25865198</ArticleId></ArticleIdList></Reference><Reference><Citation>Mounce B.C., Olsen M.E., Vignuzzi M., Connor J.H. Polyamines and Their Role in Virus Infection. Microbiol. Mol. Biol. Rev. 2017;81:e00029-17. doi: 10.1128/MMBR.00029-17.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/MMBR.00029-17</ArticleId><ArticleId IdType="pmc">PMC5706744</ArticleId><ArticleId IdType="pubmed">28904024</ArticleId></ArticleIdList></Reference><Reference><Citation>Firpo M.R., Mounce B.C. Diverse Functions of Polyamines in Virus Infection. Biomolecules. 2020;10:628. doi: 10.3390/biom10040628.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/biom10040628</ArticleId><ArticleId IdType="pmc">PMC7226272</ArticleId><ArticleId IdType="pubmed">32325677</ArticleId></ArticleIdList></Reference><Reference><Citation>Gibson W., Roizman B. Compartmentalization of Spermine and Spermidine in the Herpes Simplex Virion. Proc. Natl. Acad. Sci. USA. 1971;68:2818&#x2013;2821. doi: 10.1073/pnas.68.11.2818.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.68.11.2818</ArticleId><ArticleId IdType="pmc">PMC389533</ArticleId><ArticleId IdType="pubmed">5288261</ArticleId></ArticleIdList></Reference><Reference><Citation>Mounce B.C., Cesaro T., Moratorio G., Hooikaas P.J., Yakovleva A., Werneke S.W., Smith E.C., Poirier E.Z., Simon-Loriere E., Prot M., et al. Inhibition of Polyamine Biosynthesis Is a Broad-Spectrum Strategy against RNA Viruses. J. Virol. 2016;90:9683&#x2013;9692. doi: 10.1128/JVI.01347-16.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.01347-16</ArticleId><ArticleId IdType="pmc">PMC5068521</ArticleId><ArticleId IdType="pubmed">27535047</ArticleId></ArticleIdList></Reference><Reference><Citation>Mastrodomenico V., Esin J.J., Qazi S., Khomutov M.A., Ivanov A.V., Mukhopadhyay S., Mounce B.C. Virion-Associated Polyamines Transmit with Bunyaviruses to Maintain Infectivity and Promote Entry. ACS Infect. Dis. 2020;6:2490&#x2013;2501. doi: 10.1021/acsinfecdis.0c00402.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acsinfecdis.0c00402</ArticleId><ArticleId IdType="pubmed">32687697</ArticleId></ArticleIdList></Reference><Reference><Citation>Mounce B.C., Cesaro T., Vlajni&#x107; L., Vidi&#x146;a A., Vallet T., Weger-Lucarelli J., Passoni G., Stapleford K.A., Levraud J.-P., Vignuzzi M. Chikungunya Virus Overcomes Polyamine Depletion by Mutation of NsP1 and the Opal Stop Codon To Confer Enhanced Replication and Fitness. J. Virol. 2017;91:e00344-17. doi: 10.1128/JVI.00344-17.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.00344-17</ArticleId><ArticleId IdType="pmc">PMC5512238</ArticleId><ArticleId IdType="pubmed">28539441</ArticleId></ArticleIdList></Reference><Reference><Citation>Roberts S., Ullman B. Parasite Polyamines as Pharmaceutical Targets. Curr. Pharm. Des. 2017;23:3325&#x2013;3341. doi: 10.2174/1381612823666170601101644.</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/1381612823666170601101644</ArticleId><ArticleId IdType="pubmed">28571553</ArticleId></ArticleIdList></Reference><Reference><Citation>Casero R.A., Stewart T.M., Pegg A.E. Polyamine Metabolism and Cancer: Treatments, Challenges and Opportunities. Nat. Rev. Cancer. 2018;18:681&#x2013;695. doi: 10.1038/s41568-018-0050-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41568-018-0050-3</ArticleId><ArticleId IdType="pmc">PMC6487480</ArticleId><ArticleId IdType="pubmed">30181570</ArticleId></ArticleIdList></Reference><Reference><Citation>Fabian C.J., Kimler B.F., Brady D.A., Mayo M.S., Chang C.H.J., Ferraro J.A., Zalles C.M., Stanton A.L., Masood S., Grizzle W.E., et al. A Phase II Breast Cancer Chemoprevention Trial of Oral &#x3b1;-Difluoromethylornithine: Breast Tissue, Imaging, and Serum and Urine Biomarkers. Clin. Cancer Res. 2002;8:3105&#x2013;3117.</Citation><ArticleIdList><ArticleId IdType="pubmed">12374678</ArticleId></ArticleIdList></Reference><Reference><Citation>Simoneau A.R., Gerner E.W., Nagle R., Ziogas A., Fujikawa-Brooks S., Yerushalmi H., Ahlering T.E., Lieberman R., McLaren C.E., Anton-Culver H., et al. The Effect of Difluoromethylornithine on Decreasing Prostate Size and Polyamines in Men: Results of a Year-Long Phase IIb Randomized Placebo-Controlled Chemoprevention Trial. Cancer Epidemiol. Biomark. Prev. 2008;17:292&#x2013;299. doi: 10.1158/1055-9965.EPI-07-0658.</Citation><ArticleIdList><ArticleId IdType="doi">10.1158/1055-9965.EPI-07-0658</ArticleId><ArticleId IdType="pmc">PMC2515594</ArticleId><ArticleId IdType="pubmed">18268112</ArticleId></ArticleIdList></Reference><Reference><Citation>Firpo M.R., Mastrodomenico V., Hawkins G.M., Prot M., Levillayer L., Gallagher T., Simon-Loriere E., Mounce B.C. Targeting Polyamines Inhibits Coronavirus Infection by Reducing Cellular Attachment and Entry. ACS Infect. Dis. 2020 doi: 10.1021/acsinfecdis.0c00491.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acsinfecdis.0c00491</ArticleId><ArticleId IdType="pmc">PMC7539557</ArticleId><ArticleId IdType="pubmed">32966040</ArticleId></ArticleIdList></Reference><Reference><Citation>Dial C.N., Tate P.M., Kicmal T.M., Mounce B.C. Coxsackievirus B3 Responds to Polyamine Depletion via Enhancement of 2A and 3C Protease Activity. Viruses. 2019;11:403. doi: 10.3390/v11050403.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v11050403</ArticleId><ArticleId IdType="pmc">PMC6563312</ArticleId><ArticleId IdType="pubmed">31052199</ArticleId></ArticleIdList></Reference><Reference><Citation>Bergeron R., Weimar W., Luchetta G., Streiff R., Weigand J., Perrin J., Schreier K., Porter C., Yao G., Dimova H. Drug Metabolism and Disposition: The Biological Fate of Chemicals: Metabolism and Pharmacokinetics of N1,N11-Diethylnorspermine. Drug Metab. Dispos. 1995;10:1117&#x2013;1125.</Citation><ArticleIdList><ArticleId IdType="pubmed">8654201</ArticleId></ArticleIdList></Reference><Reference><Citation>Tate P.M., Mastrodomenico V., Mounce B.C. Ribavirin Induces Polyamine Depletion via Nucleotide Depletion to Limit Virus Replication. Cell Rep. 2019;28:2620&#x2013;2633. doi: 10.1016/j.celrep.2019.07.099.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2019.07.099</ArticleId><ArticleId IdType="pubmed">31484073</ArticleId></ArticleIdList></Reference><Reference><Citation>Kenyon T.K., Lynch J., Hay J., Ruyechan W., Grose C. Varicella-Zoster Virus ORF47 Protein Serine Kinase: Characterization of a Cloned, Biologically Active Phosphotransferase and Two Viral Substrates, ORF62 and ORF63. J. Virol. 2001;75:8854&#x2013;8858. doi: 10.1128/JVI.75.18.8854-8858.2001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.75.18.8854-8858.2001</ArticleId><ArticleId IdType="pmc">PMC115131</ArticleId><ArticleId IdType="pubmed">11507231</ArticleId></ArticleIdList></Reference><Reference><Citation>Mousstache N. Polyamines Stimulate DNA-Dependent RNA Synthesis Catalyzed by Vaccinia Virus. Biochim. Biophys. Acta. 1985;826:113&#x2013;120. doi: 10.1016/0167-4781(85)90116-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0167-4781(85)90116-2</ArticleId><ArticleId IdType="pubmed">4052428</ArticleId></ArticleIdList></Reference><Reference><Citation>Saeed M., Kapell S., Hertz N.T., Wu X., Bell K., Ashbrook A.W., Mark M.T., Zebroski H.A., Neal M.L., Flodstr&#xf6;m-Tullberg M., et al. Defining the Proteolytic Landscape during Enterovirus Infection. PLoS Pathog. 2020;16:e1008927. doi: 10.1371/journal.ppat.1008927.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1008927</ArticleId><ArticleId IdType="pmc">PMC7549765</ArticleId><ArticleId IdType="pubmed">32997711</ArticleId></ArticleIdList></Reference><Reference><Citation>Marcotte L.L., Wass A.B., Gohara D.W., Pathak H.B., Arnold J.J., Filman D.J., Cameron C.E., Hogle J.M. Crystal Structure of Poliovirus 3CD Protein: Virally Encoded Protease and Precursor to the RNA-Dependent RNA Polymerase. J. Virol. 2007;81:3583&#x2013;3596. doi: 10.1128/JVI.02306-06.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.02306-06</ArticleId><ArticleId IdType="pmc">PMC1866080</ArticleId><ArticleId IdType="pubmed">17251299</ArticleId></ArticleIdList></Reference><Reference><Citation>Palmenberg A.C. Proteolytic Processing of Picornaviral Polyprotein. Annu. Rev. Microbiol. 1990;44:603&#x2013;623. doi: 10.1146/annurev.mi.44.100190.003131.</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev.mi.44.100190.003131</ArticleId><ArticleId IdType="pubmed">2252396</ArticleId></ArticleIdList></Reference><Reference><Citation>Petersen J.F., Cherney M.M., Liebig H.D., Skern T., Kuechler E., James M.N. The Structure of the 2A Proteinase from a Common Cold Virus: A Proteinase Responsible for the Shut-off of Host-Cell Protein Synthesis. EMBO J. 1999;18:5463&#x2013;5475. doi: 10.1093/emboj/18.20.5463.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/emboj/18.20.5463</ArticleId><ArticleId IdType="pmc">PMC1171615</ArticleId><ArticleId IdType="pubmed">10523291</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim B.-K., Ko H., Jeon E.-S., Ju E.-S., Jeong L.S., Kim Y.-C. 2,3,4-Trihydroxybenzyl-Hydrazide Analogues as Novel Potent Coxsackievirus B3 3C Protease Inhibitors. Eur. J. Med. Chem. 2016;120:202&#x2013;216. doi: 10.1016/j.ejmech.2016.03.085.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ejmech.2016.03.085</ArticleId><ArticleId IdType="pubmed">27191615</ArticleId></ArticleIdList></Reference><Reference><Citation>Lim B.-K., Yun S.-H., Ju E.-S., Kim B.-K., Lee Y.-J., Yoo D.-K., Kim Y.-C., Jeon E.-S. Soluble Coxsackievirus B3 3C Protease Inhibitor Prevents Cardiomyopathy in an Experimental Chronic Myocarditis Murine Model. Virus Res. 2015;199:1&#x2013;8. doi: 10.1016/j.virusres.2014.11.030.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.virusres.2014.11.030</ArticleId><ArticleId IdType="pubmed">25485472</ArticleId></ArticleIdList></Reference><Reference><Citation>Cai Q., Yameen M., Liu W., Gao Z., Li Y., Peng X., Cai Y., Wu C., Zheng Q., Li J., et al. Conformational Plasticity of the 2A Proteinase from Enterovirus 71. J. Virol. 2013;87:7348&#x2013;7356. doi: 10.1128/JVI.03541-12.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.03541-12</ArticleId><ArticleId IdType="pmc">PMC3700279</ArticleId><ArticleId IdType="pubmed">23616646</ArticleId></ArticleIdList></Reference><Reference><Citation>Kandolf R., Hofschneider P.H. Molecular Cloning of the Genome of a Cardiotropic Coxsackie B3 Virus: Full-Length Reverse-Transcribed Recombinant CDNA Generates Infectious Virus in Mammalian Cells. Proc. Natl. Acad. Sci. USA. 1985;82:4818&#x2013;4822. doi: 10.1073/pnas.82.14.4818.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.82.14.4818</ArticleId><ArticleId IdType="pmc">PMC390996</ArticleId><ArticleId IdType="pubmed">2410905</ArticleId></ArticleIdList></Reference><Reference><Citation>Schneider C.A., Rasband W.S., Eliceiri K.W. NIH Image to ImageJ: 25 Years of Image Analysis. Nat. Methods. 2012;9:671&#x2013;675. doi: 10.1038/nmeth.2089.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nmeth.2089</ArticleId><ArticleId IdType="pmc">PMC5554542</ArticleId><ArticleId IdType="pubmed">22930834</ArticleId></ArticleIdList></Reference><Reference><Citation>Madhubala R. Thin-Layer Chromatographic Method for Assaying Polyamines. In: Morgan D.M.L., editor. Polyamine Protocols. Humana Press; Totowa, NJ, USA: 1998. pp. 131&#x2013;136. Methods in Molecular BiologyTM.</Citation><ArticleIdList><ArticleId IdType="pubmed">9463828</ArticleId></ArticleIdList></Reference><Reference><Citation>Desmyter J., Melnick J.L., Rawls W.E. Defectiveness of Interferon Production and of Rubella Virus Interference in a Line of African Green Monkey Kidney Cells (Vero) J. Virol. 1968;2:955&#x2013;961. doi: 10.1128/JVI.2.10.955-961.1968.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.2.10.955-961.1968</ArticleId><ArticleId IdType="pmc">PMC375423</ArticleId><ArticleId IdType="pubmed">4302013</ArticleId></ArticleIdList></Reference><Reference><Citation>Urin V., Shemesh M., Schreiber G. CRISPR/Cas9-Based Knockout Strategy Elucidates Components Essential for Type 1 Interferon Signaling in Human HeLa Cells. J. Mol. Biol. 2019;431:3324&#x2013;3338. doi: 10.1016/j.jmb.2019.06.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jmb.2019.06.007</ArticleId><ArticleId IdType="pubmed">31207241</ArticleId></ArticleIdList></Reference><Reference><Citation>Li K., Chen Z., Kato N., Gale M., Lemon S.M. Distinct Poly(I-C) and Virus-Activated Signaling Pathways Leading to Interferon-&#x3b2; Production in Hepatocytes*. J. Biol. Chem. 2005;280:16739&#x2013;16747. doi: 10.1074/jbc.M414139200.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M414139200</ArticleId><ArticleId IdType="pubmed">15737993</ArticleId></ArticleIdList></Reference><Reference><Citation>Farhadian S., Shareghi B., Saboury A.A. Exploring the Thermal Stability and Activity of &#x3b1;-Chymotrypsin in the Presence of Spermine. J. Biomol. Struct. Dyn. 2017;35:435&#x2013;448. doi: 10.1080/07391102.2016.1147984.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/07391102.2016.1147984</ArticleId><ArticleId IdType="pubmed">26923152</ArticleId></ArticleIdList></Reference><Reference><Citation>Agbowuro A.A., Huston W.M., Gamble A.B., Tyndall J.D.A. Proteases and Protease Inhibitors in Infectious Diseases. Med. Res. Rev. 2018;38:1295&#x2013;1331. doi: 10.1002/med.21475.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/med.21475</ArticleId><ArticleId IdType="pubmed">29149530</ArticleId></ArticleIdList></Reference><Reference><Citation>Chang K.-O., Kim Y., Lovell S., Rathnayake A.D., Groutas W.C. Antiviral Drug Discovery: Norovirus Proteases and Development of Inhibitors. Viruses. 2019;11:197. doi: 10.3390/v11020197.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v11020197</ArticleId><ArticleId IdType="pmc">PMC6410195</ArticleId><ArticleId IdType="pubmed">30823509</ArticleId></ArticleIdList></Reference><Reference><Citation>Field H.J., Goldthorpe S.E. Antiviral Drug Resistance. Trends Pharmacol. Sci. 1989;10:333&#x2013;337. doi: 10.1016/0165-6147(89)90069-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0165-6147(89)90069-2</ArticleId><ArticleId IdType="pubmed">2686131</ArticleId></ArticleIdList></Reference><Reference><Citation>Goyal L., Supko J.G., Berlin J., Blaszkowsky L.S., Carpenter A., Heuman D.M., Hilderbrand S.L., Stuart K.E., Cotler S., Senzer N.N., et al. Phase 1 Study of N(1),N(11)-diethylnorspermine (DENSPM) in Patients with Advanced Hepatocellular Carcinoma. Cancer Chemother. Pharm. 2013;72:1305&#x2013;1314. doi: 10.1007/s00280-013-2293-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00280-013-2293-8</ArticleId><ArticleId IdType="pubmed">24121453</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>